Association between antinuclear antibodies and antibodies against cyclic citrullinated peptides in patients from an Austrian rheumatology outpatient clinic._x000D_

Wegscheider, P; Psenak, O; Greil, R; Studnicka-Benke, A; EULAR annual report. 2009; -10th EULAR congress; 10.-13.06.2009; Kopenhagen.

Two Cycles of ABVD Followed by Involved Field Radiotherapy with 20 Gray (Gy) Is the New Standard of Care in the Treatment of Patients with Early-Stage Hodgkin Lymphoma: Final Analysis of the Randomized German Hodgkin Study Group (GHSG) HD10. Study Supported by the Deutsche Krebshilfe and in Part by the Competence Network Malignant Lymphoma.

Engert, A; Diehl, V; Pluetschow, A; Eich, HT; Herrmann, R; Doerken, B; Kanz, L; Greil, R; Markova, J; Fuchs, M; Borchmann, P; Mueller-Hermelink, HK; Mueller, RP; Blood. 2009; 114(22):716–51st annual meeting of the American Society of Hematology; 05.-08.12.2009; New Orleans, LA.

Combined modality treatment with intensified chemotherapy and dose-reduced involved field radiotherapy in patients with early unfavourable Hodgkin lymphoma (HL): final analysis of the German Hodgkin Study Group (GHSG) HD11 Trial.

Borchmann, P; Diehl, V; Goergen, H; Mueller, H; Mueller, RP; Eich, HT; Mueller-Hermelink, HK; Herrmann, R; Markova, J; Ho, AD; Hiddemann, W; Doerken, B; Greil, R; Engert, A; Blood. 2009; 114(22):717–51st annual meeting of the American Society of Hematology; 05.-08.12.2009; New Orleans, LA.

Diagnose Rheuma – was nun?

Psenak, O; MINI MED STUDIUM; 11.03.2009; Salzburg. 2009.

The case of a patient with refractory SLE.

Psenak, O; International Eular Course on SLE; 30.08.-05.09.2009; Pisa, Italien. 2009.

Oxaliplatin, irinotecan, and cetuximab in advanced gastric cancer. First efficacy results of a multicenter phase II trial (AGMT Gastric-2) of the Arbeitsgemeinschaft Medikamentoese Tumortherapie (AGMT)

Woell, E; Greil, R; Eisterer, W; Fridrik, M; Grunberger, B; Zabernigg, A; Mayrbaurl, B; Russ, G; Thaler, J; ASCO Annual Meeting Proceedings, 15S_x000D_ _x000D_ . 2009. 27: 4538-4538.

Rheumatoide Arthritis Serie Teil III

Psenak, O; Studnicka-Benke, A; Greil, R; Der Salzburger Arzt. 2009. 22 (7/8): 17-21.

Rheumatoide Arthritis Serie Teil II

Psenak, O; Studnicka-Benke, A; Greil, R; Der Salzburger Arzt. 2009. 22 (6): 14-16.

Is Higher Efficacy Always at the Price of More Side Effects during Chemotherapy?

Mlineritsch, B; Breast Care (Basel). 2009; 4(3): 162-165.

Triple-negative breast cancers express receptors for growth hormone-releasing hormone (GHRH) and respond to GHRH antagonists with growth inhibition.

Köster, F; Engel, JB; Schally, AV; Hönig, A; Schröer, A; Seitz, S; Hohla, F; Ortmann, O; Diedrich, K; Buchholz, S; Breast Cancer Res Treat. 2009; 116(2):273-279